Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 8.6611.3414.7129.3720.80

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 8.66 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20258.66
Mar202411.34
Mar202314.71
Mar202229.37
Mar202120.80

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 8.66
-23.63
Mar2024 11.34
-22.91
Mar2023 14.71
-49.91
Mar2022 29.37
41.20
Mar2021 20.8 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹866.9 Cr -6.5% -16.5% 125.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,590.0 Cr -2% -6.1% -6.7% Stock Analytics
DIVIS LABORATORIES ₹170,577.0 Cr -0.8% -0.8% 8.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,301.0 Cr 0% 2.7% 11% Stock Analytics
CIPLA ₹120,471.0 Cr -0.6% -2.6% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,660.0 Cr -1.3% 0.6% -6.4% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-6.5%

-16.5%

125.6%

SENSEX

-1%

-1.2%

7.9%


You may also like the below Video Courses